CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (899,378)	$ (2,230,504)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts, net of recoveries	167,496	0
Depreciation and amortization expense	164,658	63,751
Deferred income tax	0	3,065
Stock-based compensation expense	247,717	83,848
Amortization of deferred financing costs	37,926	29,914
Amortization of debt discount	0	115,609
Change in fair value of warrant and conversion feature liabilities	(822,222)	213,718
Changes in assets and liabilities:
Accounts receivable	(774,087)	108,827
Other receivables	265,980	(120,151)
Due from affiliates	453	(14,748)
Prepaid expenses and other current assets	(215,182)	20,698
Other assets	2,762	6,570
Accounts payable and accrued liabilities	(317,451)	790,613
Deferred financing cost	0	513,347
Deferred rent liability	33,584	0
Medical liabilities	(158,668)	(112,904)
Net cash used in operating activities	(2,266,412)	(528,347)
Cash flows from investing activities:
Property and equipment acquired	(163,511)	0
Net cash used in investing activities	(163,511)	0
Cash flows from financing activities:
Principal payments on lines of credit	(12,500)	0
Distributions to non-controlling interest shareholder	(450,000)	(595,418)
Proceeds from the exercise of warrants	132,002	0
Net cash used in financing activities	(330,498)	(595,418)
Net decrease in cash and cash equivalents	(2,760,421)	(1,123,765)
Cash and cash equivalents, beginning of period	9,270,010	5,014,242
Cash and cash equivalents, end of period	6,509,589	3,890,477
Supplementary disclosures of cash flow information:
Interest paid	7,142	100,959
Income taxes paid	$ 16,400	$ 32,197